Encarna Cruz
Encarna Cruz is the director general of the Spanish Association of Biosimilar Medicines (BioSim). She is actively involved in advocating for the development of biosimilars in Spain, highlighting the challenges and delays in bringing these alternatives to market, particularly in the context of expiring patents for original high-cost medications like Keytruda.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 6.00 | 0.04% | +0% | 46,754,778 | 18,620 | $1,400,000 | 558$ |
| Totals | 1 | 46,754,778 | 18,620 | $1,400,000 | 558$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Encarna Cruz is the general director of the Asociación Española de Medicamentos Biosimilares.
6